Wellington Management Group
ABBV icon

Wellington Management Group’s AbbVie ABBV Stock Holding History

Wellington Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-322
Closed -$436K – 2188
2017
Q4 		$436K Buy
+322
New +$30.3K ﹤0.01% 2070

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group's ABBV Position: Q2 2026 in Review

Wellington Management Group reduced its AbbVie (ABBV) stake by 27% in Q2 2026, selling an estimated $396M and leaving 5,055,589 shares worth $1.27B. The position accounts for 0.22% of the portfolio, ranked #108.

Wellington Management Group first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. The position peaked at $3.41B in Q4 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Wellington Management Group held 5,055,589 shares of AbbVie worth $1.27B as of Q2 2026.
  • Wellington Management Group sold 1,842,227 AbbVie shares in Q2 2026, an estimated $396M.
  • AbbVie made up 0.22% of Wellington Management Group's portfolio in Q2 2026, its #108 holding.
  • Wellington Management Group first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
  • Wellington Management Group's AbbVie position peaked at $3.41B in Q4 2025.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.